Rize Medical Cannabis a.Life Sciences UE/ IE00BJXRZ273 /
| NAV6/1/2023 | Chg.+0.0165 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2.6344USD | +0.63% | reinvestment | Equity Worldwide | Davy Global Fund M. ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | - | - | -12.37 | 14.72 | 18.08 | 0.10 | 3.51 | 3.30 | -13.23 | 1.53 | 34.63 | 6.76 | - |
| 2021 | 14.30 | 13.40 | 9.01 | -8.35 | 1.89 | -0.29 | -10.90 | -7.90 | -11.19 | -2.25 | -15.31 | 1.23 | -19.65% |
| 2022 | -6.57 | -1.79 | 0.56 | -19.33 | -11.33 | -12.86 | 4.80 | 0.19 | -14.52 | 6.92 | 1.92 | -6.32 | -47.31% |
| 2023 | 10.28 | -3.98 | -3.84 | -2.50 | -10.20 | 0.63 | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 23.88% | 23.64% | 34.80% | 37.35% | -% |
| Sharpe ratio | -1.12 | -1.49 | -0.85 | -0.64 | - |
| Best month | +10.28% | +10.28% | +10.28% | +34.63% | - |
| Worst month | -10.20% | -10.20% | -14.52% | -19.33% | - |
| Maximum loss | -24.23% | -24.23% | -34.38% | -76.68% | - |
| Outperformance | - | - | - | - | - |
All quotes in USD
Performance
| YTD | -10.28% | ||
|---|---|---|---|
| 6 Months | -17.38% | ||
| 1 Year | -26.28% | ||
| 3 Years | -49.93% | ||
| 5 Years | - | ||
| Since start | -47.68% | ||
| Year | |||
| 2022 | -47.31% | ||
| 2021 | -19.65% | ||